Literature DB >> 31845882

[Hormone treatment for short statured children? For a critical approach to sociocultural norms about short stature].

Maria Cristina Murano1.   

Abstract

Children's growth and height are thoroughly and regularly scrutinized by paediatricians and parents alike. A general consensus in treating short statured children with growth hormone (GH) exists when short stature is one of the symptoms of their pathological condition (e.g. Turner syndrome, small for gestational age, chronic renal insufficiency and Prader-Willi syndrome). Idiopathic short stature is instead a controversial diagnostic because it is based on the exclusion of any known medical causes of short stature. By proposing a critical reading of sociocultural norms about short stature, this article suggests that it is important to give a voice to concerned children and that the ethical debate about GH treatment should investigate the best ways in which children can take part in the decision-making process.
© 2019 médecine/sciences – Inserm.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31845882     DOI: 10.1051/medsci/2019173

Source DB:  PubMed          Journal:  Med Sci (Paris)        ISSN: 0767-0974            Impact factor:   0.818


  1 in total

1.  Significance of recombinant human growth hormone therapy in promoting growth and development of children with idiopathic short stature.

Authors:  Wenbiao Han; Jing Zhang; Tao Song; Yanni Han
Journal:  Pak J Med Sci       Date:  2022 Sep-Oct       Impact factor: 2.340

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.